March 5, 2026 — Leads & Copy — Aditxt, Inc. (Nasdaq: ADTX) has announced a 1-for-8 reverse split of its common stock, effective at the opening of trading on the Nasdaq Capital Market on March 9, 2026. The company’s stock will continue to trade under the ticker symbol ADTX.
The reverse stock split was approved by Aditxt’s stockholders at a special meeting held on February 13, 2026. The final ratio was determined by the company’s board of directors.
The new CUSIP number for Aditxt’s common stock will be 007025877 as a result of the reverse stock split. Every eight shares of issued and outstanding common stock will be exchanged for one share, with any fractional shares rounded up to the nearest whole share. Following the reverse stock split, the company will have approximately 517,856 shares of common stock issued and outstanding.
Adjustments will also be made to the company’s outstanding warrants and stock options. The number of shares convertible or exercisable will be adjusted to reflect the reverse split, as will the exercise prices of these securities.
Aditxt said the reverse stock split is intended to bring the company into compliance with Nasdaq’s minimum bid price requirement.
Additional information about the reverse stock split can be found in Aditxt’s definitive proxy statement filed with the Securities and Exchange Commission on December 16, 2025.
Aditxt, Inc. describes itself as a social innovation platform accelerating health innovations. The company says its ecosystem of research institutions, industry partners, and shareholders drives its mission to “Make Promising Innovations Possible Together.”
Aditxt operates a model that aims to democratize innovation, ensuring every stakeholder’s voice is heard and valued.
Source: Aditxt, Inc.
